ENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II
MELBOURNE, Australia, Oct. 22, 2025 (GLOBE NEWSWIRE) — ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense…
Browsing Tag
ENA Respiratory
1 post